Is cognitive deficit related to immune-cell beta-NGF in multiple sclerosis patients?
In RRMS beta-NGF is strongly linked to cognitive performance, which makes it an attractive therapeutic target. It might play a neuroprotective role in MS, especially in the cognitive domain.
These data suggest that 5-LOX and FLAP inhibitors may be useful in the treatment of CAA and AD.